journal article·2012-09

Hydroxyapatite additive influenced the bioactivity of bioactive nano-titania ceramics and new bone-forming capacity

Zhensheng Li, Xiaozhan Yang, Hongfeng Guo, Xiaochao Yang, Lili Sun, Shiwu Dong

Journal of Nanoparticle Research· Volume 14· Issue 9
Publisher page

Abstract

Bioceramics plays an important role in bone-substitutes. In this study, titania porous ceramics with excellent bioactivity were prepared using hydroxyapatite (HA, 10 vol.% contents) as a grain growth inhibitor. The pure TiO2 porous ceramics were also prepared as a control. After sintered at 1,000 °C with a pressureless sintering method, the particle size of the pure TiO2 and TiO2/HA (10 vol.%) porous ceramics were 450 and 310 nm, respectively. Each of the porous ceramics presented numerous pores, which were cross-connected. The size of the pores ranged from 100 to 300 μm. There were also profuse micropores inside the pore wall and between the particles. A SBF soaking experiment demonstrated that the HA additive played an important role in promoting apatite formation. The cell proliferation demonstrated that osteoblasts on the TiO2/HA (10 vol.%) porous ceramics proliferated faster than that on the pure TiO2 ceramics. The histological sections and EDX assay results of the two porous ceramics also illustrated that TiO2/HA (10 vol.%) composite ceramics combined with Ca and P elements induced much better apatite formation than that of the pure TiO2 ceramics. These results indicated that titania ceramics combined with HA holds great promise for bone-substitutes.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Titanium Alloys Microstructure and Properties · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (17)

Show source-provided references
1. Aksakal B, Yildirim S, Gul H (2007) Metallurgical failure analysis of various implant materials used in orthopedic applications. J Fail Anal Prev 4:17–2310.1007/s11668-996-0007-9 ↗
2. Dimitrievska S, Bureau MN, Antoniou J, Mwale F, Petit A, Lima RS, Marple BR (2011) Titania-hydroxyapatite nanocomposite coatings support human mesenchymal stem cells osteogenic differentiation. J Biomed Mater Res A 98A:576–58810.1002/jbm.a.32964 ↗
3. Gordin DM, Gloriant T, Texier G, Thibon I, Ansel D, Duval JL, Nagel MD (2005) Synthesis, structure and electrochemical behavior of a beta Ti–12Mo–5Ta alloy as new biomaterial. Mater Lett 59:2936–294110.1016/j.matlet.2004.09.063 ↗
4. Jensen H, Soloview A, Sogaard EG (2005) XPS and FTIR investigation of the surface properties of different prepared titania nano-powders. Appl Surf Sci 246:239–24910.1016/j.apsusc.2004.11.015 ↗
5. Kawashita M, Kim HM, Kokubo T (2003) Apatite-forming ability of carboxyl group-containing polymer gels in a simulated body fluid. Biomaterials 24:2477–248410.1016/S0142-9612(03)00050-4 ↗
6. Lee SH, Kim HW, Lee EJ (2006) Hydroxyapatite TiO2 hybrid coating on Ti implants. J Biomater Appl 20:195–20810.1177/0885328206050518 ↗
7. Leonor IB, Baran ET, Kawashita M (2008) Growth of a bonelike apatite on chitosan microparticles after a calcium silicate treatment. Acta Biomater 4:1349–135910.1016/j.actbio.2008.03.003 ↗
8. Liu HN, Webster TJ (2011) Enhanced biological and mechanical properties of well-dispersed nanophase ceramics in polymer composites: from 2D to 3D printed structures. Mater Sci Eng C 31:77–8910.1016/j.msec.2010.07.013 ↗
9. Michiko S, Elliott B, Webster TJ (2009) Enhanced osteoblast adhesion on hydrothermally treated hydroxyapatite/titania/poly(lactide-co-glycolide) sol–gel titanium coatings. Biomaterals 20:6143–6150
10. Piveteau LD, Moner I, Girona M (1999) Thin films of calcium phosphate and titanium dioxide by a sol–gel route: a new method for coating medical implants. J Mater Sci Mater Med 10:161–16710.1023/A:1008985423644 ↗
11. Schwartz AD, Mardinger O, Levin L (2009) Marginal bone loss pattern around hydroxyapatite-coated versus commercially pure titanium implants after up to 12 years of follow-up. Int J Oral Maxillofac Implants 20:238–244
12. Seramak T, Serbinski W (2010) Preparation of the porous biomaterial based on titanium alloy for orthopaedic implants. J Biomech 43:S55–S5610.1016/S0021-9290(10)70118-4 ↗
13. Webster TJ, Ejiofor JU (2004) Increased osteoblast adhesion on nanophase metals: Ti, Ti6Al4V, and CoCrMo. Biomaterials 25:4731–473910.1016/j.biomaterials.2003.12.002 ↗
14. Xu LC, Siedlecki CA (2007) Effects of surface wettability and contact time on protein adhesion to biomaterial surfaces. Biomaterials 28:3273–328310.1016/j.biomaterials.2007.03.032 ↗
15. Yang BC, Uchida M, Kim HM (2004) Preparation of bioactive titanium metal via anodic oxidation treatment. Biomaterials 25:1003–101010.1016/S0142-9612(03)00626-4 ↗
16. Yazici H, Ergun C, Bermek H (2008) An in vitro evaluation of the Ca/P ratio for the cytocompatibility of nano-to-micron particulate calcium phosphates for bone regeneration. Acta Biomater 4:1472–147910.1016/j.actbio.2008.02.025 ↗
17. Zhou Y, Niinomi M, Akahori T (2005) Corrosion resistance and biocompatibility of Ti–Ta alloys for biomedical application. Mater Sci Eng A 398:28–3610.1016/j.msea.2005.03.032 ↗